Jeil Pharmaceutical Co Ltd (271980) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.054x

Based on the latest financial reports, Jeil Pharmaceutical Co Ltd (271980) has a cash flow conversion efficiency ratio of 0.054x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩13.23 Billion ≈ $8.96 Million USD) by net assets (₩243.59 Billion ≈ $165.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jeil Pharmaceutical Co Ltd (271980) liquidity interval to measure how many days the company can operate on defensive assets alone.

Jeil Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Jeil Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jeil Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jeil Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Empery Digital Inc. NASDAQ:EMPD	-0.021x
Samhaellsbyggnadsbolaget i Norden AB Series D ST:SBB-D	-0.001x
Bank of the James Financial Group NASDAQ:BOTJ	0.024x
FG Merger II Corp. Common stock NASDAQ:FGMC	0.006x
Icon Group TA:ICON	-0.040x
Fortune Oriental Co Ltd TW:2491	0.034x
Raízen S.A. SA:RAIZ4	-0.553x
Greenheart Gold Inc. V:GHRT	-0.089x

Annual Cash Flow Conversion Efficiency for Jeil Pharmaceutical Co Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Jeil Pharmaceutical Co Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see Jeil Pharmaceutical Co Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩219.32 Billion ≈ $148.63 Million	₩3.21 Billion ≈ $2.18 Million	0.015x	+146.19%
2023-12-31	₩157.03 Billion ≈ $106.42 Million	₩-4.98 Billion ≈ $-3.38 Million	-0.032x	+67.42%
2022-12-31	₩155.60 Billion ≈ $105.45 Million	₩-15.15 Billion ≈ $-10.26 Million	-0.097x	-185.29%
2021-12-31	₩167.35 Billion ≈ $113.41 Million	₩19.10 Billion ≈ $12.94 Million	0.114x	+203.36%
2020-12-31	₩172.48 Billion ≈ $116.89 Million	₩-19.05 Billion ≈ $-12.91 Million	-0.110x	-164.84%
2019-12-31	₩170.04 Billion ≈ $115.24 Million	₩28.96 Billion ≈ $19.62 Million	0.170x	+46.80%
2018-12-31	₩184.93 Billion ≈ $125.33 Million	₩21.45 Billion ≈ $14.54 Million	0.116x	+590.46%
2017-12-31	₩177.99 Billion ≈ $120.62 Million	₩-4.21 Billion ≈ $-2.85 Million	-0.024x	--

About Jeil Pharmaceutical Co Ltd

KO:271980 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$105.96 Million

₩156.35 Billion KRW

Market Cap Rank

#19059 Global

#917 in Korea

Share Price

₩10730.00

Change (1 day)

-1.01%

52-Week Range

₩9700.00 - ₩17390.00

All Time High

₩104611.38